ReviewFrontiers in medicine2025
A review of cutaneous manifestations of HTLV-associated adult T-cell leukemia/lymphoma.
Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mimicry in Cutaneous Malignancy-Rare Forms of Mycosis Fungoides as Diagnostic Pitfalls: A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adult T-cell leukemia/lymphoma (ATLL) is a rare aggressive mature T-cell neoplasm caused by the human T-cell leukemia virus type 1 (HTLV-1). The disease predominantly affects patients from endemic regions of Japan, the Caribbean, Sub-Saharan Africa, and South America. Cutaneous involvement of ATLL is common and may appear before or in the absence of systemic involvement. However, the lesions are non-specific and often mimic more common inflammatory and neoplastic skin diseases, making diagnosis challenging. Moreover, morphology is variable among patients, ranging from macules and papules to tumors and erythroderma. Recent data suggests that the presence of cutaneous lesions and lesion morphology are important for prognostication and for guiding treatment. Here, we provide an overview of the spectrum of cutaneous findings in ATLL, highlighting their diagnostic, prognostic, and therapeutic implications. We emphasize the importance of early recognition and workup of suspicious skin lesions, particularly in endemic regions or high-risk populations. Finally, we describe fundamental concepts and controversies, and highlight current knowledge gaps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.